Fulvestrant

규격

129453-61-8CAS 번호

642-998-6EC 번호

(7R,8R,9S,13S,14S,17S)-13-methyl-7-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl]-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diolIUPAC 명칭

C32H47F5O3S화학식

606.8 g/mol분자량

Fulvestrant; 129453-61-8; Faslodex; ICI 182,780; Ici 182780; ICI-182780; ZD-9238; DTXSID4022369; fulvestrantum; ZD9238; (7R,8R,9S,13S,14S,17S)-13-methyl-7-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl]-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol; ICI182780; Faslodex(ICI 182,780); 22X328QOC4; NSC-759879; 7alpha-(9-((4,4,5,5,5-Pentafluoropentyl)sulfinyl)nonyl)estra-1,3,5(10)-triene-3,17beta-diol; DTXCID202369; Estra-1,3,5(10)-triene-3,17-diol, 7-[9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl]-, (7alpha,17beta)-; CHEBI:31638; NSC719276; Estra-1,3,5(10)-triene-3,17-diol, 7-(9-((4,4,5,5,5-pentafluoropentyl)sulfinyl)nonyl)-, (7alpha,17beta)-; (1S,3aS,3bR,4R,9bS,11aS)-11a-methyl-4-[9-(4,4,5,5,5-pentafluoropentanesulfinyl)nonyl]-1H,2H,3H,3aH,3bH,4H,5H,9bH,10H,11H,11aH-cyclopenta[a]phenanthrene-1,7-diol; (7alpha,17beta)-7-{9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl}estra-1(10),2,4-triene-3,17-diol; (1S,3aS,3bR,4R,9bS,11aS)-11a-methyl-4-(9-(4,4,5,5,5-pentafluoropentanesulfinyl)nonyl)-1H,2H,3H,3aH,3bH,4H,5H,9bH,10H,11H,11aH-cyclopenta(a)phenanthrene-1,7-diol; (7alpha,17beta)-7-(9-((4,4,5,5,5-pentafluoropentyl)sulfinyl)nonyl)estra-1(10),2,4-triene-3,17-diol; (7R,8R,9S,13S,14S,17S)-13-methyl-7-(9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl)-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta(a)phenanthrene-3,17-diol; ZM182780; RefChem:57293; 7-(9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl)estra-1,3,5(10)-triene-3,17-diol; L02BA03; (1S,9R,11S,14S,15S)-15-methyl-9-(9-(4,4,5,5,5-pentafluoropentanesulfinyl)nonyl)tetracyclo(8.7.0.02,7.011,15)heptadeca-2,4,6-triene-5,14-diol; 642-998-6; 7a-(9-((4,4,5,5,5,-Pentafluoropentyl)sulphinyl)nonyl)-estra-1,3,5(10)-triene-3,17b-diol; ZM-182780; Fulvestrant S enantiomer; Fulvestrant (Standard); C32H47F5O3S; CHEMBL1358; (7R,8R,9S,13S,14S,17S)-13-methyl-7-(9-((4,4,5,5,5-pentafluoropentyl)sulfinyl)nonyl)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diol; Fulvestrant (Faslodex); Fulvestrant [USAN]; Fulvestrant R enantiomer; (7R,13S,17S)-13-methyl-7-(9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diol; ZM 182780; Faslodex (TN); (7alpha,17beta)-7-[9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl]estra-1,3,5(10)-triene-3,17-diol; (7alpha,17beta)-7-{9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl}estra-1,3,5(10)-triene-3,17-diol; CAS-129453-61-8; ZD 182780; 1316849-17-8; Fluvestrant; UNII-22X328QOC4; Fulvestrant?; CCRIS 8741; ZD-182780; Fulvestrant CRS; HSDB 7658; NCGC00024964-02; Fulvestrant [USAN:USP:INN:BAN]; FULVESTRANT [MI]; FULVESTRANT [INN]; FULVESTRANT [JAN]; FULVESTRANT [VANDF]; SCHEMBL8209; FULVESTRANT [MART.]; BIDD:PXR0136; FULVESTRANT [USP-RS]; FULVESTRANT [WHO-DD]; MLS006010187; BIDD:ER0348; Fulvestrant (JAN/USP/INN); FULVESTRANT [EMA EPAR]; Fulvestrant, >98% (HPLC); GTPL1015; orb1306347; Fulvestrant - Bio-X trade mark; SCHEMBL29353866; EX-A959; FULVESTRANT [ORANGE BOOK]; ICI 182,780 (Fulvestrant); MSK8055; FULVESTRANT [EP MONOGRAPH]; FULVESTRANT [USP IMPURITY]; GLXC-03001; HMS2090N22; HMS3260G10; HMS3712A06; FULVESTRANT [USP MONOGRAPH]; (7R,8R,9S,13S,14S,17S)-13-methyl-7-(9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diol; Tox21_110939; Tox21_202604; Tox21_303656; Tox21_500114; BDBM50169743; EBC-11252; HB2501; HY-13636R; MSK8055-100M; AKOS015895669; Fulvestrant for system suitability CRS; Tox21_110939_1; AC-4693; CCG-220082; CCG-221418; CS-1267; DB00947; FF23615; LP00114; NSC 759879; NSC-719276; SDCCGSBI-0633685.P001; ICI 182 780; NCGC00164789-02; NCGC00164789-04; NCGC00257357-01; NCGC00260152-01; NCGC00260799-01; NCGC00386134-10; NCGC00386134-19; (7R,8S,9S,13S,14S,17S)-13-methyl-7-[9-(4,4,5,5,5-pentafluoropentylsulfinyl) nonyl]-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol; AS-13024; BI167222; DA-63628; HY-13636; SMR001456109; CS-0694849; F1144; F8147; Fulvestrant Solution in Methanol, 100ug/mL; NS00004276; S1191; Fulvestrant, Vetec(TM) reagent grade, >98%; D01161; EN300-120628; AB01273957-01; AB01273957-02; AB01273957-03; AB01273957_04; Q5508491; BRD-A85667082-001-12-7; Fulvestrant, European Pharmacopoeia (EP) Reference Standard; Fulvestrant, United States Pharmacopeia (USP) Reference Standard; Fulvestrant for system suitability, European Pharmacopoeia (EP) Reference Standard; (13S,17S)-13-Methyl-7-[9-(4,4,5,5,5-pentafluoro-pentane-1-sulfinyl)-nonyl]-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diol; (7a,17b)-7-[9-[4,4,5,5,5-Pentafluoropentyl)sulfinyl]nonyl]estra-1,3,5(10)-triene-3,17-diol; (7R,13S,17S)-13-Methyl-7-[9-(4,4,5,5,5-pentafluoro-pentane-1-sulfinyl)-nonyl]-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diol; (7R,8R,9S,13S,14S,17S)-13-methyl-7-(9-(4,4,5,5,5-pentafluoropentyldihydrosulfinyl)nonyl)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diol; (7R,8R,9S,13S,14S,17S)-13-Methyl-7-[9-(4,4,5,5,5-pentafluoro-pentane-1-sulfinyl)-nonyl]-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diol; (7R,9S,13S,14S,17S)-13-Methyl-7-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl]-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol; 13-Methyl-7-[9-(4,4,5,5,5-pentafluoro-pentane-1-sulfinyl)-nonyl]-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diol; 13-Methyl-7-[9-(4,5,5,5-pentafluoropentylsulfinyl)nonyl]-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diol; 7.ALPHA.-(9-(4,4,5,5,5-PENTAFLUOROPENTYLSULPHINYL)NONYL)ESTRA-1,3,5(10)-TRIENE-3,17.BETA.-DIOL; 7alpha-[9-(4,4,5,5,5-pentafluoro-pentylsulfinyl)nonyl]estra-1,3,5(10)-triene-3,17beta-diol; 7alpha-[9-(4,4,5,5,5-Pentafluoropentane-1-sulfinyl)nonyl]estra-1,3,5(10)-triene-3,17beta-diol; 7alpha-{9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl}estra-1(10),2,4-triene-3,17beta-diol; ESTRA-1,3,5(10)-TRIENE-3,17-DIOL, 7-(9-((4,4,5,5,5-PENTAFLUOROPENTYL)SULFINYL)NONYL)-, (7.ALPHA.,17.BETA.)-; Estra-1,5(10)-triene-3,17-diol, 7-[9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl]-, (7.alpha.,17.beta.)-동의어